David R. Rahn & Associates Inc. Edwards Lifesciences Corp Put Options Transaction History
David R. Rahn & Associates Inc.
- $323 Million
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding EW
# of Institutions
1,350Shares Held
457MCall Options Held
9.76MPut Options Held
3.92M-
Vanguard Group Inc Valley Forge, PA62.6MShares$4.68 Billion0.08% of portfolio
-
Black Rock Inc. New York, NY51MShares$3.81 Billion0.11% of portfolio
-
Wellington Management Group LLP Boston, MA31.5MShares$2.36 Billion0.37% of portfolio
-
State Street Corp Boston, MA26.3MShares$1.96 Billion0.07% of portfolio
-
Geode Capital Management, LLC Boston, MA13.5MShares$1.01 Billion0.07% of portfolio
About Edwards Lifesciences Corp
- Ticker EW
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 618,259,968
- Market Cap $46.3B
- Description
- Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...